Proteostasis and Beyond: ATF6 in Ischemic Disease.

Area of Science:

• Cellular Biology
• Pathology
• Neuroscience

Background:

• Endoplasmic reticulum (ER) stress is a key factor in ischemic diseases such as stroke and myocardial infarction (MI).
• ER stress triggers the unfolded protein response (UPR), influencing cell survival after ischemia.
• The activating transcription factor 6 (ATF6) pathway of the UPR has shown protective effects in ischemia/reperfusion (I/R) injury models.

Purpose of the Study:

• To review the protective role of ATF6 signaling in various tissues against ischemic damage.
• To discuss preclinical findings on the therapeutic potential of targeting ATF6 for ischemia-related disorders.

Main Methods:

• Literature review of studies on ER stress, UPR, and ATF6 in ischemic diseases.
• Analysis of preclinical data investigating ATF6-targeted therapies.

Main Results:

• ATF6 signaling demonstrates a protective role in mitigating I/R injury across multiple disease models.
• Evidence supports ATF6 as a viable therapeutic target for ischemic conditions.

Conclusions:

• ATF6 pathway activation is crucial for cellular protection against ischemic insults.
• Pharmacological targeting of ATF6 presents a promising therapeutic strategy for managing stroke, MI, and other ischemia-related conditions.